SCHEMBL29930407

SCHEMBL29930407

C[Si](C)(C)CCOCn1nc(-c2cccc(N)c2)c2cc(Br)cnc21

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 1/20 0.39
MERTK Q12866 4/20 0.38
DGAT1 O75907 3/20 0.35
ALOX5AP P20292 4/20 0.33
FEN1 P39748 4/20 0.33
MAP4K4 O95819 2/20 0.32
NPC1 O15118 1/20 0.32
AXL P30530 1/20 0.31
TYRO3 Q06418 1/20 0.31
CSNK1D P48730 1/20 0.31
PDE5A O76074 1/20 0.30
PDE1A P54750 1/20 0.30
PDE1B Q01064 1/20 0.30
PDE3B Q13370 1/20 0.30
PDE1C Q14123 1/20 0.30
PDE3A Q14432 1/20 0.30
BTK Q06187 1/20 0.30
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1592834 0.89 MERTK (0.39) DYRK1BMERTKDGAT1ALOX5APFEN1
SCHEMBL29930815 0.87 AXL (0.41) DYRK1BMERTKDGAT1NPC1AXL
SCHEMBL30645456 0.85 DGAT1 (0.36) DGAT1ALOX5APFEN1
SCHEMBL29113927 0.85 DGAT1 (0.36) DGAT1ALOX5APFEN1
SCHEMBL29930812 0.84 PDE4A (0.39)
SCHEMBL29930809 0.83 DGAT1 (0.37) DYRK1BMERTKDGAT1NPC1AXL
SCHEMBL29930508 0.83 DGAT1 (0.36) DYRK1BMERTKDGAT1PDE1B
SCHEMBL29930779 0.82 AXL (0.41) DYRK1BMERTKDGAT1MAP4K4AXL
SCHEMBL29930954 0.82 DYRK1A (0.46) DYRK1BPDE5APDE1APDE1BPDE3B
SCHEMBL29930401 0.81 DYRK1B (0.40) DYRK1BMERTKDGAT1AXLPDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed